WILLIAM HUDSON: Open Payments
NPI 1922064914 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 14 payments from 7 companies in 2025. Trend: 2023 $252 · 2024 $204 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $69 |
| ABBVIE INC. | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Alkermes, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: AUSTEDO XR, VRAYLAR, SPRAVATO, Auvelity, ABILIFY MAINTENA, REXULTI, ARISTADA, TRINTELLIX.
Industry payments across GA — which companies pay providers there.
